Related Experiment Videos
Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality
C Löwbeer1, P Stenvinkel, R Pecoits-Filho
1Division of Clinical Chemistry, Department of Medical Laboratory Sciences and Technology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden. christian.lowbeer@medilab.se
Insights
Elevated cardiac troponin T (cTnT) levels in predialysis patients predict mortality. Higher cTnT also correlates with inflammation markers like IL-6 and CRP, indicating its role in end-stage renal disease prognosis.
Area of Science:
- Cardiology
- Nephrology
- Biomarkers
Background:
- Cardiac troponin T (cTnT) is a sensitive marker of myocardial damage.
- Elevated cTnT in hemodialysis patients is linked to poor outcomes.
- The prognostic value of cTnT in predialysis patients and its association with inflammatory markers require further investigation.
Purpose of the Study:
- To evaluate the predictive value of cTnT in patients before starting dialysis.
- To examine the relationship between cTnT and inflammatory markers, including C-reactive protein (CRP) and interleukin-6 (IL-6).
Main Methods:
- A cohort follow-up study involving 115 end-stage renal disease (ESRD) patients.
- Analysis of cTnT using a third-generation assay.
- Survival analysis using Kaplan-Meier and Cox regression, with all-cause mortality as the endpoint.
Main Results:
- Serum cTnT correlated positively with CKMB, IL-6, and CRP, and negatively with serum albumin.
- Diabetic patients and those with cardiovascular disease (CVD) had significantly higher cTnT levels.
- Patients with cTnT ≥ 0.10 μg/L had higher cumulative mortality.
- Diabetes Mellitus (DM) and cTnT were independently associated with mortality in multivariate analysis.
Conclusions:
- Serum cTnT ≥ 0.10 μg/L is a significant predictor of mortality in patients initiating dialysis.
- Positive correlations between cTnT and inflammatory markers suggest an association between inflammation and cTnT levels.
- cTnT is an independent predictor of mortality in ESRD patients commencing dialysis.
Objectives:
Cardiac troponin T (cTnT) is a highly sensitive and specific marker of myocardial damage. It has been shown that elevated serum concentrations of cTnT in haemodialysis (HD) patients are associated with poor prognostic outcome. The aim of the present study was to investigate the predictive value of cTnT in samples from predialysis patients and to investigate associations between cTnT and inflammatory markers, such as C-reactive protein (CRP) and interleukin-6 (IL-6).
Design:
Cohort, follow-up study.
Setting:
Huddinge University Hospital, Sweden.
Subjects:
A total of 115 (62% males, 28% diabetic patients) end-stage renal disease (ESRD) patients (52 +/- 1 years), of which 29% had cardiovascular disease (CVD), were studied shortly before the onset of dialysis therapy. Sixty-four patients started peritoneal dialysis (PD) as renal replacement therapy, whilst 49 started HD during the follow-up.
Main Outcome Measures:
The cTnT was analysed with the third generation TnT assay on Elecsys 2010. The prognostic value was calculated for cTnT, IL-6, age, CVD, malnutrition, diabetes mellitus (DM) and gender. Survival analyses were made with Kaplan-Meier and Cox regression analyses, with all-cause mortality as the clinical end point (mean follow-up period 2.7 +/- 0.1 years).
Results:
Significant correlations were found between cTnT and CKMB (rho = 0.52, P < 0.0001), IL-6 (rho = 0.23, P < 0.05), CRP (rho = 0.30, P < 0.05), and serum albumin (rho = -0.31, P < 0.001), respectively. Diabetic patients had higher median serum cTnT level (0.09 microg L-1; range <0.01-0.51 vs. 0.04 microg L-1; range <0.01-0.67 microg L-1; P < 0.005) compared with nondiabetic patients. Likewise, patients with CVD had a significantly higher median level (0.08 microg L-1; range <0.01-0.67 microg L-1 vs. 0.04 microg L-1; range <0.01-0.61 microg L-1; P < 0.01) of cTnT compared with patients without CVD. Patients with cTnT > or =0.10 microg L-1 had a higher cumulative mortality rate than patients with cTnT < 0.10 microg L-1 (chi2 = 7.04; P < 0.01). Whilst age, CVD, malnutrition, DM, IL-6, cTnT and male gender were associated with poor outcome in the univariate analysis, only DM (P < 0.05) and cTnT (P < 0.05) were independently associated with mortality in a multivariate analysis.
Conclusions:
The present study demonstrates that serum concentrations of cTnT > or =0.10 microg L-1 is a significant predictor of mortality in patients starting dialysis. Moreover, the positive correlations between cTnT and IL-6, and CRP, respectively, suggest an association between inflammation and cTnT levels. Finally, the results of the present study suggest that cTnT is an independent predictor of mortality in ESRD patients starting dialysis.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Myocarditis II: Clinical Features and Diagnostic Tests